• Modus Therapeutics opens the first exercise window for TO 2030 warrants on Sept. 14, 2026, running through Sept. 27, 2026.
• Exercise price set at SEK 0.4 per new share.
• Full exercise of 38,084,264 warrants would issue 38,084,264 shares, raising about SEK 15.2 million before costs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modus Therapeutics Holding AB published the original content used to generate this news brief on September 11, 2026, and is solely responsible for the information contained therein.